Micropattern-based platform as a physiologically relevant model to study epithelial morphogenesis and nephrotoxicity.
Drug-development
Microenvironment
Micropatterns
Nephrotoxicity
Organ-on-achip
Tubulogenesis
Journal
Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
16
11
2018
revised:
04
07
2019
accepted:
05
07
2019
pubmed:
22
7
2019
medline:
22
9
2020
entrez:
22
7
2019
Statut:
ppublish
Résumé
Tubulogenesis in epithelial organs often initiates with the acquisition of apicobasal polarity, giving rise to the formation of small lumens that expand and fuse to generate a single opened cavity. In this study, we present a micropattern-based device engineered to generate epithelial tubes through a process that recapitulates in vivo tubule morphogenesis. Interestingly, tubulogenesis in this device is dependent on microenvironmental cues such as cell confinement, extracellular matrix composition, and substrate stiffness, and our set-up specifically allows the control of these extracellular conditions. Additionally, proximal tubule cell lines growing on micropatterns express higher levels of drug transporters and are more sensitive to nephrotoxicity. These tubes display specific morphological defects that can be linked to nephrotoxicity, which would be helpful to predict potential toxicity when developing new compounds. This device, with the ability to recapitulate tube formation in vitro, has emerged as a powerful tool to study the molecular mechanisms involved in organogenesis and, by being more physiologically relevant than existing cellular models, becomes an innovative platform to conduct drug discovery assays.
Identifiants
pubmed: 31326655
pii: S0142-9612(19)30438-7
doi: 10.1016/j.biomaterials.2019.119339
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
119339Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.